International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net


ORIGINAL RESEARCH ARTICLE
Int J Pharm Bio Sci Volume 12 Issue 2, 2021 (April-June), Pages:152-159

Evaluation of the anti-viral activity of nanoparticles on HSV-1 virus

Sana Al Attas*
DOI: http://dx.doi.org/10.22376/ijpbs.2021.12.2.b152-159
Abstract:

In the present study, the antiviral potential of various nanoparticles was evaluated, such as BiOCI, Nickel Oxide (NiO), Calcium carbonate (CaCO3), MgZO24, and Magnesium hydroxide (Mg (OH)2). The antiviral effect of these nanoparticles was evaluated on the Herpes Simplex virus-1 (HSV-1) virus.  The antiviral potential of various nanoparticles have been evaluated, such as Bioci Bismuth Oxychloride, Nickel Oxide (NiO), Calcium carbonate (CaCO3), MgZO 24  Magnesium Zink Oxide, and Magnesium hydroxide (Mg (OH)2). The antiviral effect of these nanoparticles was evaluated on the Herpes Simplex virus-1 (HSV-1) virus. The maximum non-toxic dose of nanoparticles was found to be  100 μg/ml,  and this concentration was used to analyze their antiviral effects.  None of the tested nanoparticles exhibited significant HSV-1 inhibition in the cell-based assay and MTT assay. However, in the Plaque assay, some inhibition of viral activity was seen in the case of NiO and CaCO3  nanoparticles as compared to virus control. This antiviral activity was similar to the positive control of usnic acid, used in this study. Since these nanoparticles did not show any significant anti-viral activity in MTT assay,  the activity of these compounds, i.e., NiO and CaCO3  nanoparticles needs to be further confirmed by using higher doses of these compounds, and also further optimization of the anti-viral essay is required in order to achieve the significant antiviral activity.

Keywords: Viral infections; Nanoparticles; Antiviral activity; MTT assay; Plaque assay
Full HTML:

REFERENCES

1.       Domingo E. Mechanisms of viral emergence. Vet Res. 2010;41(6):38. doi: 10.1051/vetres/2010010, PMID 20167200.

2.       Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275(1):177-82. doi: 10.1016/j.jcis.2004.02.012, PMID 15158396.

3.       Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16(10):2346-53. doi: 10.1088/0957-4484/16/10/059, PMID 20818017.

4.       Panacek A, Kvítek L, Prucek R, Kolar M, Vecerova R, Pizúrova N, Sharma VK, Nevecna T, Zboril R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006;110(33):16248-53. doi: 10.1021/jp063826h, PMID 16913750.

5.       Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticles? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007;73(6):1712-20. doi: 10.1128/AEM.02218-06, PMID 17261510.

6.       Li Y, Leung P, Yao L, Song QW, Newton E. Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect. 2006;62(1):58-63. doi: 10.1016/j.jhin.2005.04.015, PMID 16099072.

7.       Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, Lau GK, Che CM. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther. 2008;13(2):253-62. PMID 18505176.

8.       Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem. 2009;20(8):1497-502. doi: 10.1021/bc900215b, PMID 21141805.

9.       Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005;29:3-6.

10.     Sun L, Singh AK, Vig K, Pillai S, Shreekumar R, Singh SR. Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Biotechnol. 2008;4:149-58.

11.     Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16(10):8894-918. doi: 10.3390/molecules16108894, PMID 22024958.

12.     Shtro AA, Zarubaev VV, Luzina OA, Sokolov DN, Salakhutdinov NF. Derivatives of usnic acid inhibit a broad range of influenza viruses and protect mice from lethal influenza infection. Antivir Chem Chemother. 2015;24(3-4):92-8. doi: 10.1177/2040206616636992, PMID 27022094.

13.     Sokolov DN, Zarubaev VV, Shtro AA, Polovinka MP, Luzina OA, Komarova NI, Salakhutdinov NF, Kiselev OI. Antiviral activity of (-)- and (+)- usnic acids and their derivatives against influenza virus A (H1N1) 2009. Bioorg Med Chem Lett. 2012;22(23):7060-4. doi: 10.1016/j.bmcl.2012.09.084, PMID 23099095.

14.     Cocchietto M, Skert N, Nimis PL, Sava G. A review on usnic acid, an interesting natural compound. Naturwissenschaften. 2002;89(4):137-46. doi: 10.1007/s00114-002-0305-3, PMID 12061397.

15.     Al-Hazmi F, Alnowaiser F, Al-Ghamdi AA, Al-Ghamdi AA, Aly MMF, Al-Tuwirqi RM, El-Tantawy F. (A new large – scale synthesis of magnesium oxide nanowires: structural and antibacterial properties). Superlattices Microstruct. May 25 2012;52(2):200-9. doi: 10.1016/j.spmi.2012.04.013, PMID 24748719.

[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions